...查看全文
美股滚雪球2022-07-22 14:13
CNS药物领域不错的公司:$Xenon制药(XENE)$ &$Intra-cellular(ITCI)$ 被收购的概率比较大。
$恒瑞医药(SH600276)$查看全文
chuminhua2021-10-05 10:48
10月4日,在Xenon Pharmaceuticals宣布在研药物XEN1101用于局灶性癫痫成年患者的辅助治疗的IIb期研究达到其主要疗效终点后,该公司的股票在周一翻了一番。
X-TOLE试验随机选抽取了325名局灶性癫痫的成年人,让他们接受三种每天一次的XEN1101剂量中的一种或安慰剂。结果显示,与安慰剂相比,这...查看全文
andrewmed2021-03-10 09:27
文章来源:“凯莱英药闻”微信公众号
2021年3月8日,Xenon Pharmaceuticals宣布与西奈山伊坎医学院合作,以推进一项研究者发起的概念验证性、双盲、随机、平行设计、安慰剂对照2期临床试验,评估XEN1101用于治疗重度抑郁症(MDD)和快感缺失。
为了测试XEN1101与安慰剂相比在MDD和重度快感...查看全文
智通财经APP获悉,10月4日(周一)美股盘初,截至北京时间22:02,专注于神经学的生物制药公司Xenon Pharmaceuticals(XENE.US)涨74.78%,报27.265美元。早前,该公司公布了2b期X-Tole临床试验的积极结果,该临床试验评估了XEN1101的临床有... 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-07-03 AccNo: 0000902664-18-002713 Size: 111 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 内部交易: 2018-06-21,Director,AZAB MOHAMMAD ,期权,10288普通股, $3.70
$Xenon Pharmaceuticals Inc.(XENE)$ 内部交易: 2018-06-21,Director,TARNOW MICHAEL M ,期权,12345普通股, $3.43
$Xenon Pharmaceuticals Inc.(XENE)$ 内部交易: 2018-06-14,Director,PATOU GARY ,期权,8230普通股, $3.70
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-06-13 AccNo: 0001564590-18-015497 Size: 109 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement ...
$Xenon Pharmaceuticals Inc.(XENE)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-06-08 AccNo: 0001422849-18-000162 Size: 8 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-06-05 AccNo: 0001564590-18-015055 Size: 91 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-05-15 AccNo: 0001564590-18-013520 Size: 127 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-05-08 AccNo: 0001564590-18-011917 Size: 872 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001564590-18-011914 Size: 320 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接